EURETINA Highlights

flipper_slider

Editor's Choice

Baruch Kuppermann discusses the early use of intravitreal steroids for patients with diabetic macular edema.

EURETINA Highlights Videos

Hemal Mehta discusses the currently available intravitreal steroid therapies for the treatment of diabetic macular oedema and the supporting clinical trial and real-world evidence.
Manish Nagpal discusses the latest advances in OCT angiography and the current and future diagnostic applications.
Baruch Kuppermann discusses the early use of intravitreal steroids for patients with diabetic macular edema.
Albert Augustin discusses the use of anti-VEGF agents and intravitreal steroids in the treatment of diabetic macular edema.
Pravin Dugel discusses his highlights from EURETINA 2017.
Pravin Dugel discusses the unmet need in the treatment of neovascular AMD and the research into new agents, such as brolucizumab.
Hemal Mehta discusses the strengths and limitations of anti-VEGF therapy and when intravitreal steroids should be considered.
Roberto Gallego-Pinazo discusses multi-modal retinal imaging and how he implements it in his day-to-day clinical practice.
Anat Loewenstein discusses intravitreal and laser therapies in the treatment of diabetic macular oedema.
European Ophthalmic Review's Editorial Board member Anat Loewenstein shares her highlights from the 2017 EURETINA meeting.